Novel formulation could provide a better treatment for patients with prostate cancer – News-Medical.Net

A novel formulation of the prostate cancer drug abiraterone acetate – currently marketed as Zytiga – will dramatically improve the quality of life for people suffering from prostate cancer, as pre-clinical trials by the University of South Australia show the …